We are live on ! Find out more
LC

Lindbrook Capital Portfolio holdings

AUM $1.08B
1-Year Est. Return 10.14%
This Fund
S&P 500
This Quarter Est. Return
+10.25%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$1.07B
AUM Growth
+$67.5M
Cap. Flow
-$16.8M
Cap. Flow %
-1.57%
Top 10 Hldgs %
43.59%
Holding
2,793
New
103
Increased
1,023
Reduced
644
Closed
145

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$8.03M
2
SNAP icon
Snap
SNAP
+$4.75M
3
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$1.11M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.09M
5
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$1.03M

Top Sells

Rank Stock Value
1
GBDC icon
Golub Capital BDC
GBDC
+$15.8M
2
NVDA icon
NVIDIA
NVDA
+$3.72M
3
COIN icon
Coinbase
COIN
+$2.93M
4
AVGO icon
Broadcom
AVGO
+$2.69M
5
VXUS icon
Vanguard Total International Stock ETF
VXUS
+$1.89M

Sector Composition

Rank Sector Weight
1 Technology 15.66%
2 Financials 13.81%
3 Healthcare 6.79%
4 Consumer Discretionary 3.87%
5 Communication Services 3.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FORM icon
2301
FormFactor
FORM
$9.17B
$1.69K ﹤0.01%
37
– –
FCN icon
2302
FTI Consulting
FCN
$4.18B
$1.68K ﹤0.01%
8
-14
-64% -$2.81K
SUPN icon
2303
Supernus Pharmaceuticals
SUPN
$2.77B
$1.67K ﹤0.01%
49
– –
ICHR icon
2304
Ichor Holdings
ICHR
$2.56B
$1.66K ﹤0.01%
43
+5
+13% +$194
LTC
2305
LTC Properties
LTC
$2.15B
$1.66K ﹤0.01%
+51
New +$1.63K
AVDL
2306
DELISTED
Avadel Pharmaceuticals
AVDL
$1.66K ﹤0.01%
98
– –
BRSL
2307
Brightstar Lottery PLC
BRSL
$2.03B
$1.65K ﹤0.01%
73
– –
UTL icon
2308
Unitil
UTL
$980M
$1.62K ﹤0.01%
31
-65
-68% -$3.27K
KFRC icon
2309
Kforce
KFRC
$1.06B
$1.62K ﹤0.01%
23
– –
GFF icon
2310
Griffon
GFF
$4.86B
$1.61K ﹤0.01%
22
– –
CDMO
2311
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$1.61K ﹤0.01%
240
– –
MBIN icon
2312
Merchants Bancorp
MBIN
$2.49B
$1.6K ﹤0.01%
37
– –
JJSF icon
2313
J&J Snack Foods
JJSF
$1.71B
$1.59K ﹤0.01%
11
-8
-42% -$1.21K
ATRO icon
2314
Astronics
ATRO
$3.84B
$1.58K ﹤0.01%
100
+4
+4% +$59
FVRR icon
2315
Fiverr
FVRR
$339M
$1.58K ﹤0.01%
75
– –
MATX icon
2316
Matsons
MATX
$6.18B
$1.57K ﹤0.01%
14
– –
TDOC icon
2317
Teladoc Health
TDOC
$1.3B
$1.57K ﹤0.01%
104
-412
-80% -$7.48K
MTN icon
2318
Vail Resorts
MTN
$5.3B
$1.56K ﹤0.01%
7
+1
+17% +$222
STEL
2319
DELISTED
Stellar Bancorp
STEL
$1.56K ﹤0.01%
64
– –
TRIP icon
2320
TripAdvisor
TRIP
$1.26B
$1.56K ﹤0.01%
56
– –
UHAL icon
2321
U-Haul Holding Co
UHAL
$14.6B
$1.55K ﹤0.01%
23
– –
ECPG icon
2322
Encore Capital Group
ECPG
$2.13B
$1.55K ﹤0.01%
+34
New +$1.68K
SLCA
2323
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$1.55K ﹤0.01%
125
– –
MODV
2324
DELISTED
ModivCare
MODV
$1.55K ﹤0.01%
66
-7
-10% -$256
ARR
2325
Armour Residential REIT
ARR
$2.36B
$1.54K ﹤0.01%
78
– –
91 92
93
94 95

Similar funds

SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
CHP
Cable Hill Partners Portland, Oregon $1.02B AUM 8.59% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
TAM
Taurus Asset Management New York $986M AUM 5.04% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.72% 1-Year Est. Return
CIG
CCM Investment Group Northfield, Minnesota $946M AUM
CCM
CAAS Capital Management New York $934M AUM 1.45% 1-Year Est. Return
WCF
West Coast Financial Santa Barbara, California $876M AUM 5.74% 1-Year Est. Return

Lindbrook Capital's Q1 2024 Portfolio in Review

As of Q1 2024, Lindbrook Capital held 2,793 positions worth $1.07B, up 6.7% from $1B the previous quarter. Its ten largest holdings account for 44% of the portfolio.

Lindbrook Capital's Q1 2024 filing shows 103 new, 1,023 increased, 644 reduced and 145 closed positions. Its largest new stake was Hess Midstream: 14,335 shares worth $518K. The largest sale was Golub Capital BDC, an estimated $15.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

  • Lindbrook Capital's largest Q1 2024 buy was Hess Midstream: 14,335 shares worth $518K.
  • Lindbrook Capital added most to Vertex Pharmaceuticals in Q1 2024, an estimated $8.03M increase.
  • Lindbrook Capital's biggest Q1 2024 reduction was Golub Capital BDC, cutting an estimated $15.8M.
  • Lindbrook Capital fully exited Splunk Inc in Q1 2024, selling an estimated $153K.
  • Lindbrook Capital's ten largest holdings make up 44% of its $1.07B portfolio in Q1 2024.
  • Lindbrook Capital opened 103 new positions and closed 145 in Q1 2024.
  • Lindbrook Capital's portfolio value rose 6.7% quarter-over-quarter to $1.07B.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.